Excerpt from ChorioretinitisSynonyms, Key Words, and Related Terms: chorioretinitis, CR, retinochoroiditis, choroidoretinitis, congenital toxoplasmosis, CTP, congenital cytomegalovirus, CMV, congenital lymphocytic choriomeningitis virus, fungal infections, retinal vessels, Toxocara infection, West Nile virus, Baylisascaris, Epstein-Barr virus, varicella-zoster virus, intrauterine growth retardation, microcephaly, microphthalmia, cataract, uveitis, hearing defect, osteomyelitis, enlarged liver, enlarged spleen, lymphadenopathy, dermal erythropoiesis, carditis, congenital heart disease, herpes simplex virus Please click here to view the full topic text: ChorioretinitisBackgroundChorioretinitis (CR) is an exudative inflammatory process that involves the retinal vessels and is usually caused by congenital viral, bacterial, or protozoan infections in neonates. Congenital toxoplasmosis (CTP) is the most common cause of infectious chorioretinitis in immunocompetent children. Congenital cytomegalovirus (CMV) infection is the second most common etiology. Fungal infections are more frequently identified, and emergent pathogens, including In the older pediatric age group, chorioretinitis is diagnosed in diverse clinical conditions and can reflect newly acquired diseases or reactivation. Chorioretinitis can result from a dissemination of Toxocara or Baylisascaris in immunocompetent patients. In severely immunodeficient patients, including those with acquired immunodeficiency syndrome (AIDS), chorioretinitis may be associated with Epstein-Barr virus (EBV), CMV, varicella-zoster virus, various fungi (eg, Candida, Aspergillus, Fusarium, dimorphic fungi), and Toxoplasma. PathophysiologyChorioretinitis causes an inflammation of the retinal vessels in reaction to a generalized infection that involves multiple organ systems. Congenital disseminated infections also manifest as intrauterine growth retardation, microcephaly, microphthalmia, cataract, uveitis, hearing defect, osteomyelitis, enlarged liver and spleen, lymphadenopathy, dermal erythropoiesis, carditis, and congenital heart disease. Vessel trauma caused by lodging Toxocara or Baylisascaris larvae may be associated with severe inflammatory responses. Although chorioretinitis that is associated with congenital viral infections tends to be stable or improves in infancy, chorioretinitis associated with asymptomatic CTP progresses for years after birth and is more likely to be clinically significant at an older age. FrequencyUnited StatesCTP occurs much less frequently in the Worldwide, chorioretinitis due to CTP is more common than chorioretinitis due to symptomatic congenital CMV. The seroprevalence rate in childbearing women is estimated at 14-30%, and the estimated incidence rate of CTP is 0.1 per 1000 births. Statistically, chorioretinitis due to CMV is more common than chorioretinitis due to CTP in the United States. Chorioretinitis occurs in approximately 14% of infants born with symptomatic congenital CMV infection. However, severely affected infants represent fewer than 10% of those with congenital infections due to maternal primoinfection with viremia during the first half of pregnancy. Chorioretinitis affects only 2% of asymptomatic infants with congenital infection. InternationalSeroprevalence rates for CTP in childbearing women are 50-80% in European countries, and the estimated incidence rate of CTP is 1-4 cases per 1000 births. However, acquired toxoplasmosis accounts for a much higher rate of ocular infections in late childhood worldwide. The prevalence of CMV seroconversion in many parts of the world reaches almost 100% in young adults. The incidence of CMV congenital infection is not well documented. Mortality/Morbidity
Age
Please click here to view the full topic text: Chorioretinitis |
| About Us | Privacy | Code of Ethics | Terms of Use | Contact Us | Advertising | Institutional Subscribers |
|
|
|||
|
| Medicine is a constantly changing science and not all therapies are clearly established. New research changes drug and treatment therapies daily. The authors, editors, and publisher of this journal have used their best efforts to provide information that is up-to-date and accurate and is generally accepted within medical standards at the time of publication. However, as medical science is constantly changing and human error is always possible, the authors, editors, and publisher or any other party involved with the publication of this article do not warrant the information in this article is accurate or complete, nor are they responsible for omissions or errors in the article or for the results of using this information. The reader should confirm the information in this article from other sources prior to use. In particular, all drug doses, indications, and contraindications should be confirmed in the package insert. FULL DISCLAIMER |